Literature DB >> 10718513

Cholinergic enhancement improves performance on working memory by modulating the functional activity in distinct brain regions: a positron emission tomography regional cerebral blood flow study in healthy humans.

M L Furey1, P Pietrini, G E Alexander, M B Schapiro, B Horwitz.   

Abstract

Previously, we have shown that physostigmine, an acetylcholinesterase inhibitor, improved performance on a working memory for faces task, as reflected by reduced reaction time (RT), and reduced task-specific regional cerebral blood flow (rCBF) in right prefrontal cortex and, further, that these reductions in RT and right frontal rCBF were significantly correlated. Here we investigated the relation between the effects of physostigmine on task performance and task-specific functional brain response throughout the cortex by examining correlations between physostigmine-related changes in rCBF in all brain areas and changes in RT. In subjects who received an infusion of physostigmine, reduced RT correlated (p<0.001) positively with reduced rCBF in right frontal cortex, left temporal cortex, anterior cingulate, and left hippocampus; and correlated with increased rCBF in medial occipital visual cortex. In subjects who received a placebo infusion of saline, no significant correlations between changes in RT and cortical rCBF were observed. The results show that cholinergically induced improvements in working memory performance are related to alterations in neural activity in multiple cortical regions, including increased neural activity in regions associated with early perceptual processing and decreased neural activity in regions associated with attention, memory encoding, and memory maintenance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10718513     DOI: 10.1016/s0361-9230(99)00219-1

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  20 in total

Review 1.  Psychoanatomical substrates of Bálint's syndrome.

Authors:  M Rizzo; S P Vecera
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

Review 2.  The treatment of cognitive impairment in schizophrenia.

Authors:  Donald C Goff; Michele Hill; Deanna Barch
Journal:  Pharmacol Biochem Behav       Date:  2010-11-27       Impact factor: 3.533

3.  Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes.

Authors:  Miriam Z Mintzer; Roland R Griffiths
Journal:  Cogn Affect Behav Neurosci       Date:  2007-06       Impact factor: 3.282

Review 4.  [Present status and future possibilities of adjuvant pharmacotherapy for aphasia].

Authors:  C Korsukewitz; C Breitenstein; M Schomacher; S Knecht
Journal:  Nervenarzt       Date:  2006-04       Impact factor: 1.214

Review 5.  Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging.

Authors:  Paul Bentley; Jon Driver; Raymond J Dolan
Journal:  Prog Neurobiol       Date:  2011-06-17       Impact factor: 11.685

6.  The prominent role of stimulus processing: cholinergic function and dysfunction in cognition.

Authors:  Maura L Furey
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

7.  Risk of Common Mental Disorders in Relation to Symptoms of Obstructive Sleep Apnea Syndrome among Ethiopian College Students.

Authors:  Ornella Rutagarama; Bizu Gelaye; Mahlet G Tadesse; Seblewengel Lemma; Yemane Berhane; Michelle A Williams
Journal:  J Sleep Disord Treat Care       Date:  2015-10-20

8.  Cholinergic enhancement reduces functional connectivity and BOLD variability in visual extrastriate cortex during selective attention.

Authors:  Emiliano Ricciardi; Giacomo Handjaras; Giulio Bernardi; Pietro Pietrini; Maura L Furey
Journal:  Neuropharmacology       Date:  2012-08-18       Impact factor: 5.250

9.  Cholinergic enhancement eliminates modulation of neural activity by task difficulty in the prefrontal cortex during working memory.

Authors:  Maura L Furey; Emiliano Ricciardi; Mark B Schapiro; Stanley I Rapoport; Pietro Pietrini
Journal:  J Cogn Neurosci       Date:  2008-07       Impact factor: 3.225

10.  In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia.

Authors:  Irina Esterlis; Mohini Ranganathan; Frederic Bois; Brian Pittman; Marina R Picciotto; Lara Shearer; Alan Anticevic; Jon Carlson; Mark J Niciu; Kelly P Cosgrove; D Cyril D'Souza
Journal:  Biol Psychiatry       Date:  2013-11-13       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.